{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T14:12:54Z","timestamp":1777126374830,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejphar.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,8,24]],"date-time":"2014-08-24T12:38:59Z","timestamp":1408883939000},"page":"254-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat"],"prefix":"10.1016","volume":"741","author":[{"given":"Henrik H.","family":"Hansen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gitte","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Paulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels","family":"Vrang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Jelsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.08.010_bib1","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.2337\/db09-0281","article-title":"Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats","volume":"58","author":"Barrera","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.08.010_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2826.2010.01995.x","article-title":"Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats","volume":"22","author":"Baumgartner","year":"2010","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib3","doi-asserted-by":"crossref","first-page":"R1030","DOI":"10.1152\/ajpregu.00734.2002","article-title":"Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression","volume":"285","author":"Bi","year":"2003","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainresrev.2009.09.008","article-title":"kappa-Opioid receptor signaling and brain reward function","volume":"62","author":"Bruijnzeel","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.ejphar.2014.08.010_bib5","doi-asserted-by":"crossref","first-page":"R1695","DOI":"10.1152\/ajpregu.00870.2004","article-title":"Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats","volume":"288","author":"Chelikani","year":"2005","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib6","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1096\/fj.09-143610","article-title":"kappa-Opioid receptors control the metabolic response to a high-energy diet in mice","volume":"24","author":"Czyzyk","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2014.08.010_bib7","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib8","doi-asserted-by":"crossref","first-page":"E1314","DOI":"10.1152\/ajpendo.00137.2013","article-title":"Nucleus accumbens GLP-1 receptors influence meal size and palatability","volume":"304","author":"Dossat","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.08.010_bib9","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.08.010_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1758-5996-5-25","article-title":"Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment","volume":"5","author":"Guedes","year":"2013","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.ejphar.2014.08.010_bib12","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/aps.2011.168","article-title":"Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DIO-rats","volume":"33","author":"Hansen","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2014.08.010_bib13","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/oby.2011.50","article-title":"Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats","volume":"19","author":"Hayes","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ejphar.2014.08.010_bib14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00125-005-1705-7","article-title":"Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors","volume":"48","author":"Holst","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2014.08.010_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(87)81430-8","article-title":"Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut","volume":"211","author":"Holst","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2014.08.010_bib16","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2014.08.010_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1463-1326.2012.01557.x","article-title":"Liraglutide: short-lived effect on gastric emptying\u2014long lasting effects on body weight","volume":"14","author":"Jelsing","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.08.010_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neulet.2009.07.011","article-title":"The effect of leptin receptor deficiency and fasting on cannabinoid receptor 1 mRNA expression in the rat hypothalamus, brainstem and nodose ganglion","volume":"463","author":"Jelsing","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2014.08.010_bib20","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1210\/en.2012-1358","article-title":"Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4","volume":"153","author":"Jessen","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2014.08.010_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.02.004","article-title":"Effect of linagliptin, alone and in combination with voglibose or exendin-4, on glucose control in male ZDF rats","volume":"729","author":"Jones","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib22","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2014.08.010_bib23","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2014.08.010_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/sj.ijo.0802206","article-title":"Entry of exendin-4 into brain is rapid but may be limited at high doses","volume":"27","author":"Kastin","year":"2003","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.ejphar.2014.08.010_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood\u2013brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0031-9384(02)00751-5","article-title":"Opioid modulation of taste hedonics within the ventral striatum","volume":"76","author":"Kelley","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2014.08.010_bib27","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","article-title":"The diverse roles of specific GLP-1 receptors in the control of food intake and the response to visceral illness","volume":"22","author":"Kinzig","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib28","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.08.010_bib29","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1021\/jm070861j","article-title":"Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness","volume":"50","author":"Madsen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.08.010_bib30","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u05f3s disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib31","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1210\/en.2005-0237","article-title":"Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively","volume":"146","author":"Neary","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2014.08.010_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000338163","article-title":"The opioid system and food intake: homeostatic and hedonic mechanisms","volume":"5","author":"Nogueiras","year":"2012","journal-title":"Obes. Facts"},{"key":"10.1016\/j.ejphar.2014.08.010_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.physbeh.2011.04.033","article-title":"Opioids as facilitators of feeding: can any food be rewarding?","volume":"104","author":"Olszewski","year":"2011","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2014.08.010_bib34","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diab.45.6.832","article-title":"Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I","volume":"45","author":"Orskov","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.08.010_bib35","doi-asserted-by":"crossref","first-page":"E701","DOI":"10.1152\/ajpendo.00024.2003","article-title":"Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect","volume":"285","author":"Prigeon","year":"2003","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.08.010_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2337\/db06-0565","article-title":"Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-IV inhibitor, vildagliptin, does not","volume":"56","author":"Raun","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.08.010_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1053\/meta.2000.6251","article-title":"Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats","volume":"49","author":"Rodriquez de Fonseca","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2014.08.010_bib38","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1210\/me.2006-0367","article-title":"Dynorphin knockout reduces fat mass and increases weight loss during fasting in mice","volume":"21","author":"Sainsbury","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1124\/jpet.111.191098","article-title":"The dipeptidyl peptidase-4 inhibitor linagliptin attenuates inflammation and accelerates epithelialization in wounds of diabetic ob\/ob mice","volume":"342","author":"Sch\u00fcrmann","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2014.08.010_bib40","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1523\/JNEUROSCI.20-04-01616.2000","article-title":"The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride","volume":"20","author":"Seeley","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib41","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/endo.137.11.8895391","article-title":"Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus","volume":"137","author":"Shughrue","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2014.08.010_bib42","first-page":"R848","article-title":"Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats","volume":"271","author":"Tang-Christensen","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diabetes.47.4.530","article-title":"Glucagon-like peptide 1(7-36) amide\u05f3s central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment","volume":"47","author":"Tang-Christensen","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.08.010_bib44","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2014.08.010_bib45","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1210\/jc.2002-021873","article-title":"Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus","volume":"88","author":"Vilsb\u00f8ll","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.08.010_bib46","doi-asserted-by":"crossref","first-page":"d7771","DOI":"10.1136\/bmj.d7771","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials","volume":"344","author":"Vilsb\u00f8ll","year":"2012","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2014.08.010_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.tics.2010.11.001","article-title":"Reward, dopamine and the control of food intake: implications for obesity","volume":"15","author":"Volkow","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib48","doi-asserted-by":"crossref","first-page":"RC5","DOI":"10.1523\/JNEUROSCI.19-10-j0006.1999","article-title":"Neurochemical characterization of hypothalamic cocaine\u2013amphetamine-regulated transcript neurons","volume":"19","author":"Vrang","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2014.08.010_bib49","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1210\/en.2008-1045","article-title":"Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety","volume":"150","author":"Williams","year":"2009","journal-title":"Endocrinology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T07:38:48Z","timestamp":1565768328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914006153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":49,"alternative-id":["S0014299914006153"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.010","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The DPP-IV inhibitor linagliptin and GLP-1 induce synergistic effects on body weight loss and appetite suppression in the diet-induced obese rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}